Trial intelligence / Profile preview

Lidocaine versus fentanyl infusion during breast cancer surgery for serum-mediated tumor cell apoptosis

IRCT20120430009593N14Phase 2Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Jan 2021
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised, single-blind trial in breast cancer comparing Lidocaine group with Fentanyl group (2 arms). Primary endpoint: Apoptosis index. Started Jan 2021; status: completed.

02

Drugs

lidocainefentanyl
03

Conditions

breast cancer

Beyond the preview

Go deeper on IRCT20120430009593N14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20120430009593N14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call